🚀 VC round data is live in beta, check it out!
- Public Comps
- Chemours
Chemours Valuation Multiples
Discover revenue and EBITDA valuation multiples for Chemours and similar public comparables like Cabot, Mesaieed Petrochemical, Dyno Nobel, POCO Holdings Co. and more.
Chemours Overview
About Chemours
The Chemours Co is a provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, paints and coatings, plastics, transportation, semiconductor, and others. The company's operating segments include Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. Geographically, the company derives a majority of its revenue from North America.
Founded
2014
HQ

Employees
5.7K
Website
Sectors
Financials (LTM)
EV
$8B
Valuation Multiples
Start free trialChemours Financials
Chemours reported last 12-month revenue of $6B and EBITDA of $777M.
In the same LTM period, Chemours generated $1B in gross profit, $777M in EBITDA, and $167M in net income.
Revenue (LTM)
Chemours P&L
In the most recent fiscal year, Chemours reported revenue of $6B and EBITDA of $332M.
Chemours is unprofitable as of last fiscal year, with gross margin of 16%, EBITDA margin of 6%, and net margin of (7%).
Financial data powered by Morningstar, Inc.
Chemours Stock Performance
Chemours has current market cap of $4B, and enterprise value of $8B.
Market Cap Evolution
Chemours' stock price is $26.95.
Chemours share price increased by 166.0% in the last year.
Chemours has an EPS (earnings per share) of $-2.57.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $8B | $4B | 2.3% | — | 47.8% | 166.0% | $-2.57 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialChemours Valuation Multiples
Chemours trades at 1.3x EV/Revenue multiple, and 10.0x EV/EBITDA.
EV / Revenue (LTM)
Chemours Financial Valuation Multiples
As of May 1, 2026, Chemours has market cap of $4B and EV of $8B.
Chemours has a P/E ratio of 24.2x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Chemours Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Chemours Margins & Growth Rates
In the most recent fiscal year, Chemours reported gross margin of 16%, EBITDA margin of 6%, and net margin of (7%).
Chemours Margins
Chemours Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Chemours Operational KPIs
Chemours' revenue per employee in the last FY averaged $1.0M, while opex per employee averaged $0.2M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
Chemours Competitors
Chemours competitors include Cabot, Mesaieed Petrochemical, Dyno Nobel, POCO Holdings Co., Gubre Fabrikalari, Shanghai Petrochemical, Viohalco, Xin Feng Ming Group, Hawkins and Avient.
Most Chemours public comparables operate across Chemicals.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 1.3x | 1.4x | 6.2x | 6.5x | |||
| 27.1x | — | — | — | |||
| 1.5x | 1.7x | 7.7x | 7.9x | |||
| 15.5x | 14.0x | 44.5x | 42.2x | |||
| 3.4x | — | 15.9x | — | |||
| 0.3x | 0.3x | 62.6x | 31.4x | |||
| 0.7x | — | 7.5x | — | |||
| 0.7x | 0.7x | 9.9x | 8.9x | |||
This data is available for Pro users. Sign up to see all Chemours competitors and their valuation data. Start Free Trial | ||||||
Chemours Investment Activity
Chemours has invested in 1 company to date.
Latest investment by Chemours was on May 10th 2022. Chemours invested in Versogen in their $15M Series A round (EV/Revenue multiple of ).
Latest Investments by Chemours
| Description | Versogen is a Santa Barbara-based developer of anion exchange membrane electrolyzers for green hydrogen production. The company manufactures hydroxide exchange membranes that enable cost-effective water splitting using renewable electricity. Its technology targets applications in fuel cells, industrial decarbonization, and energy storage, with pilots demonstrating efficiencies above 80 percent. Versogen collaborates with national labs and energy firms to scale deployment across North America and Europe. |
| HQ Country | |
| HQ City | Wilmington, DE |
| Deal Date | 10 May 2022 |
| Round | Series A |
| Raised | $15M |
| Investors | America LLC; CN Innovations; Doosan; DSC Investment; HyAxiom; TechEnergy Ventures; Chemours; TOP Ventures; Wenstone H2Tech |
| Valuation | undisclosed |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all Chemours investments and their VC round multiples. Start Free Trial | |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Chemours
| When was Chemours founded? | Chemours was founded in 2014. |
| Where is Chemours headquartered? | Chemours is headquartered in United States. |
| How many employees does Chemours have? | As of today, Chemours has over 5K employees. |
| Who is the CEO of Chemours? | Chemours' CEO is Denise M. Dignam. |
| Is Chemours publicly listed? | Yes, Chemours is a public company listed on NYSE. |
| What is the stock symbol of Chemours? | Chemours trades under CC ticker. |
| When did Chemours go public? | Chemours went public in 2015. |
| Who are competitors of Chemours? | Chemours main competitors include Cabot, Mesaieed Petrochemical, Dyno Nobel, POCO Holdings Co., Gubre Fabrikalari, Shanghai Petrochemical, Viohalco, Xin Feng Ming Group, Hawkins, Avient. |
| What is the current market cap of Chemours? | Chemours' current market cap is $4B. |
| What is the current revenue of Chemours? | Chemours' last 12 months revenue is $6B. |
| What is the current revenue growth of Chemours? | Chemours revenue growth (NTM/LTM) is 5%. |
| What is the current EV/Revenue multiple of Chemours? | Current revenue multiple of Chemours is 1.3x. |
| Is Chemours profitable? | Yes, Chemours is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Chemours? | Chemours' last 12 months EBITDA is $777M. |
| What is Chemours' EBITDA margin? | Chemours' last 12 months EBITDA margin is 13%. |
| What is the current EV/EBITDA multiple of Chemours? | Current EBITDA multiple of Chemours is 10.0x. |
| What is the current FCF of Chemours? | Chemours' last 12 months FCF is $109M. |
| What is Chemours' FCF margin? | Chemours' last 12 months FCF margin is 2%. |
| What is the current EV/FCF multiple of Chemours? | Current FCF multiple of Chemours is 71.1x. |
| How many companies Chemours has acquired to date? | Chemours hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Chemours has invested to date? | As of May 2026, Chemours has invested in 1 company. |
| What was the last Chemours investment? | On 10th May 2022 Chemours invested in Versogen, participating in a $15M Series A round, alongside America LLC, CN Innovations, Doosan, DSC Investment, HyAxiom, TechEnergy Ventures, TOP Ventures, and Wenstone H2Tech. |
| In what companies Chemours invested in? | Chemours invested in Versogen. |
See public comps similar to Chemours
Lists including Chemours
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.
